MEGAN COX: Open Payments
NPI 1619689080 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 32 payments from 10 companies in 2025. Trend: 2023 $642 · 2024 $232 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 11 | $272 |
| Evofem Biosciences, Inc. | 5 | $92 |
| Organon LLC | 3 | $73 |
| ABBVIE INC. | 3 | $59 |
| Hologic Sales and Service, LLC | 2 | $53 |
| Astellas Pharma US Inc | 3 | $52 |
| Ethicon US, LLC | 1 | $44 |
| Novo Nordisk Inc | 2 | $32 |
| PFIZER INC. | 1 | $19 |
| OptumHealth Care Solutions, LLC | 1 | $16 |
Products named: Phexxi, NEXPLANON, UBRELVY, Veozah, VISTASEAL, Wegovy, FETAL FIBRONECTIN ENZYME IMMUNOASSAY, THIRD WAVE.
Industry payments across MO — which companies pay providers there.
